Cancer Diagnostic Company MobileODT Raises $6.85M
July 6, 2017 | The Israeli cancer diagnostic company MobileODT recently completed a $6.85 million funding round led by the OrbiMed Advisors LLC venture capital fund. This brings their total funding up to $13 million since their inception in 2012. Founded by Ariel Beery and David Levitz, MobileODT uses mobile phones to detect cancer; their first product is an FDA cleared internet-connected mobile colposcope that detects cervical cancer. The product has already screened more than 16 000 women in over 25 countries.